Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2023

These following common stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

Schedule of Anti-dilutive Securities

	September 30, 2023		September 30, 2022
	(Unaudited)		(Unaudited)
Options to purchase common stock		3,737,952		1,835,452
Warrants to purchase common stock		9,148,880		2,337,274
Unvested restricted common stock		-		295,588
Total anti-dilutive securities		12,886,832		4,468,314